Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

**Registered number: 07962584 Charity number: 1146349** 

## **CAMBRIDGE SCIENCE CENTRE** 

**(A Company Limited by Guarantee)** 

**TRUSTEES' REPORT AND FINANCIAL STATEMENTS** 

**FOR THE YEAR ENDED 31 DECEMBER 2025** 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

|**CONTENTS**||
|---|---|
||Page|
|**Reference and Administrative Details of the Charity, its Trustees and Advisers**|1|
|**Trustees' Report**|2 - 8|
|**Independent Auditors' Report on the Financial Statements**|9 - 13|
|**Statement of Financial Activities**|14|
|**Balance Sheet**|15 - 16|
|**Statement of Cash Flows**|17|
|**Notes to the Financial Statements**|18 - 40|





Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2025** 

|**Trustees**|Ms A H East|
|---|---|
||Dr L J Spokes (resigned 20 May 2026)|
||Prof J Drori CBE (resigned 17 June 2026)|
||Mr J J P Marsh|
||Ms A J Weatherup|
||Ms H E Fear MBE, Chair|
||Dr J A Mellad (resigned 10 December 2025)|
||Mr B F V Cotta|
||Mr D Cuff (resigned 24 April 2026)|
||Ms S Macmillan|
||Mr J Doherty (appointed 11 March 2026)|
||Mrs T H A Sword (appointed 27 March 2026)|
||Ms A Kone-Massouma (appointed 17 April 2026)|
|**Company registered**<br>**number**<br>07962584<br>**Charity registered**<br>**number**<br>1146349<br>**Registered office**<br>44 Clifton Road<br>Cambridge<br>CB1 7ED<br>**Patrons**<br>Lord Rees of Ludlow<br>Professor Dame Athene Donald<br>**Chief Executive Officer**<br>Rebecca Porter<br>**Independent examiner**<br>PEM Audit Limited<br>Registered auditors<br>Salisbury House<br>Station Road<br>Cambridge<br>CB1 2LA<br>**Solicitors**<br>Birketts LLP<br>22 Station Road<br>Cambridge<br>CB1 2JD||



Page 1 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2025** 

The Trustees (who are directors for the purpose of the Companies Act) present their annual report together with the financial statements of the Company for the year 1 January 2025 to 31 December 2025. The Annual Report serves the purposes of both a trustees' report and a directors' report under company law. The Trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (second edition October 2019). 

Since the Company qualifies as small under section 382 of the Companies Act 2006, the Strategic Report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted. 

## **OBJECTIVES AND ACTIVITIES** 

The purpose of Cambridge Science Centre (CSC) is to inspire curiosity and interest in science and technology, helping to develop a more scientifically literate and skilled population. 

- Our main objectives, as set out in our Memorandum of Association, are to advance and develop: 

- the public understanding of science and technology, in both principle and application; 

- public engagement in scientific and technological research and discourse, particularly in relation to public policy and ethics; and 

- public access to scientific and technological development in the city of Cambridge and across East Anglia. 

We achieve these objectives by co-developing and delivering high-quality STEM (Science, Technology, Engineering and Mathematics) experiences for young people and the adults in their lives. This includes engaging school pupils and the wider public through hands-on, interactive activities and exhibits. Many of our programmes and exhibits are developed in collaboration with researchers, academics and industry partners from Cambridge’s academic and technology communities, ensuring that content is grounded in real-world research and innovation. 

We also undertake targeted outreach activity to reach underserved communities, identified through government data and in partnership with public bodies and educational organisations, to ensure that access to STEM engagement is broadened to those who may otherwise face barriers. 

The Board of Trustees confirms that it has complied with its duty under Section 17 of the Charities Act 2011 to have due regard to the Charity Commission’s guidance on public benefit. 

## **Volunteers** 

We encourage volunteers from a wide range of backgrounds, including those working in local STEM companies, schools and colleges, as well as members of our Executive Council. Following the opening of our new permanent science centre, we were delighted to reinstate our regular volunteering programme and welcome volunteers back to support our activities. 

Page 2 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

**TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **ACHIEVEMENTS AND PERFORMANCE** 

## **Appointments and Retirements** 

The following Trustee stepped down during the year: 

Dr J A Mellad on 10[th] December 2025. 

## **On site programmes and outreach operations** 

We continue to adapt our delivery, fundraising and marketing activities to ensure they remain aligned with our charitable objectives in an evolving and challenging operating environment. 

Cambridge Science Centre opened its latest venue on the Cambridge Science Park in spring 2024, with the support of Trinity College, University of Cambridge, LifeArc, Brockton Everlast and Arm. Trustees and management have been encouraged by strong levels of public participation since opening. This investment in new STEM content, exhibits, laboratory space and retail provision has enabled the Centre to establish itself as a vibrant hub for hands-on learning, embedding CSC more deeply within the Cambridge science ecosystem and expanding opportunities for young people to engage with STEM. 

In parallel, with the support of grant funding alongside that provided by Roche, Illumina and Dr Debbie Allen, CSC has sustained and expanded its outreach programme for schools and the wider community, while strengthening its presence across the Fenland region. CSC has also opened a free-to-access satellite centre in Wisbech, operating at weekends and hosting school visits throughout the week. 

During 2025, Cambridge Science Centre engaged 30,163 people across its centres and outreach activities. This included 24,091 engagements through our Cambridge-based activities, comprising 21,146 visitors, 2,372 school pupils (72 classes) and 573 community participants. At Inspire Wisbech, we engaged a further 4,613 people, including 3,036 visitors, 1,399 school pupils (30 classes) and 178 community participants. An additional 1,459 engagements were delivered through outreach activity in schools and communities. 

We have continued to extend our reach into new regions, consolidating our presence in Fenland. The Wisbech centre, located in the Horsefair Shopping Centre, provides an important access point for communities facing barriers to STEM engagement due to rurality, limited transport links and reduced exposure to growth industries. The centre welcomed over 3,000 visitors during the year, many of whom would otherwise have limited access to comparable provision. Through the support of our Executive Council and other funders, we were able to subsidise transport costs, addressing a key barrier to access. 

Our Fenland programme has included free-entry science pop-ups in market towns such as Ramsey, Wisbech and Chatteris, part-funded by the Cambridgeshire and Peterborough Combined Authority. These activities have engaged both school groups and the wider public, extending our reach and widening access to hands-on STEM experiences. The programme will continue into 2026. 

We also continued to deliver our STEM Club, a weekly after-school programme delivered during term time in partnership with North Cambridge Community Partnership (NCCP), supporting young people living in areas of higher deprivation. 

Alongside delivery, we strengthened our internal structure to support future growth, establishing three core workstreams: Partner, Translate and Engage. These align with our Mission Framework and underpin how we develop and deliver our programmes. Within this model, content is developed through our Impact Architecture (our Theory of Change), enabling a more consistent and evaluable approach to engagement, including the development of new sector-focused programmes. 

CSC continued to participate in a range of shows and festivals throughout the year, including British Science 

Page 3 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

**CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025** 

Week, Cambridge Festival, Festival on the Close, Big Biology Day, IWM Duxford Air Show, Cambridge Tech Week and Anglia Ruskin University’s Chelmsford Family Science Day. We also collaborated with community events across the Fenland region, including the Ramsey Festival, as part of our wider place-based work. 

## **Partnerships and national awareness** 

We remain very grateful to our continuing Executive Council members: AstraZeneca, MathWorks, Cemex, Anglia Ruskin University, Cambridge Consultants, Bruntwood SciTech and Brockton Everlast. We are also grateful to our corporate supporters and to the Cambridgeshire and Peterborough Combined Authority. 

We have continued to build strong partnerships with our members and supporters, including supporting corporate STEM initiatives, bringing STEM industries to life in creative and tangible ways, providing volunteering opportunities, and delivering engagement activities for staff and their families. We are also grateful to our Founders, Trustees and wider supporters for their continued generosity and support. 

We continued our membership of the Association of Independent Museums (AIM) and the Association of Science and Discovery Centres (ASDC). 

## **Fundraising** 

Throughout 2025 fundraising efforts were dedicated to: 

- Continuing to strengthen our relationship with our Executive Council members, who have remained Executive Council members and at the end of the year were in discussions with several others for 2026. 

- Soliciting major donations from Founders and Members of the Board of Trustees and their networks. 

- Seeking to widen our pool of funding with new support from trusts and foundations with an interest in STEM with whom we have not previously engaged. 

- Launching our major donor campaign and expanding our corporate sponsors and engaging new organisations in our work. 

- Applying for grants, a landscape that remained highly competitive throughout 2025 

- Continuing to play an active role with the ASDC supporting them in their campaign to raise awareness at government levels of the work science and discovery centre achieve, particularly with young learners, and to encourage financial support. 

## **FINANCIAL REVIEW** 

## **Results** 

The Charity recorded a surplus of £193,262 for the period covered by these accounts, compared with a surplus of £64,747 in 2024. 

One major donor will continue to provide a guarantee to make up any shortfall if Cambridge Science Centre has to cease its activities and its unrestricted reserves are insufficient to meet all of its liabilities. 

During this time, unrestricted income achieved was £961,804 (2024 - £466,814). During the year we received £448,005 (2024 - £514,760) in restricted grants and donations to support specific programmes. 

Resources expended totalled £1,216,547 (2024 - £916,827). 

## **Going concern** 

After making appropriate enquiries, the Trustees have reasonable expectation that Cambridge Science Centre has adequate resources to continue in operational existence for the foreseeable future. For this reason, they 

Page 4 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

**TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025** 

continue to adopt the going concern basis in preparing the financial statements. 

## **Reserves policy** 

It is the intention of the Trustees that surplus funds will be retained to further the objects of Cambridge Science Centre. 

It is the policy of the Trustees to have Reserves appropriate to our level of activity and financial risks. The level of the Reserves and Reserves policy are reviewed annually. The Trustees have set the Reserves target at £275,000 which they consider adequate to enable Cambridge Science Centre to meet all its liabilities including the cost of winding up its operations in the event that it could not continue. 

At the year end the Charity has total funds carried forward of £549,225 (2024 - £355,963) of which £312,397 (2024 - £194,286) is represented by restricted funds relating to unspent donation and grant income received for particular projects continuing into 2026. The Charity has an increase in unrestricted funds at the year-end which stood at £236,828 (2024 - £161,677) of which £207,440 (2024 - £249,513) is in a designated capital reserve as it relates to fixed assets which can only be realised on disposal. This leaves a general free reserves balance of negative £29,388 (2024 - negative £87,836). 

The Trustees have revised the three-year plan to ensure sufficient unrestricted reserves are established, at the end of the three year period, to cover the costs of a wind down, if required. The Trustees remain confident in achieving this position and encouraged by progress made thus far. Additionally, one major donor will continue to provide a guarantee to make up any shortfall if Cambridge Science Centre has to cease its activities and its unrestricted reserves are insufficient to meet all of its liabilities. This guarantee is limited to an aggregate amount of £137,500 (reducing as unrestricted reserves increase) and is enforceable until May 2027. 

## **Principal funding sources** 

Cambridge Science Centre is principally funded by grants and trusts, certain individuals and corporate donors. In addition, we are supported by sponsorships, admission charges, retail sales and collection donations. 

## **Risk management** 

The Trustees have assessed the major risks to which the Charity is exposed, in particular those related to the operations and finances of the Charity, and are satisfied that systems and procedures are in place to mitigate exposure to the major risk 

The Board of Trustees review identified risks to the business at each Board of Trustees’ meeting. The Trustees maintain a risk register and that it is reviewed regularly. Finance continues to present the key financial risks and the Trustees carry out long term planning on a regular basis, prepare annual budgets and review the financial performance against budget at each Trustees’ meeting. Certain Trustees also participated in an Audit & Risk Sub Committee. 

## **PLANS FOR FUTURE PERIODS** 

## **Future plans** 

Continuing to refine our organisational direction, ensuring alignment with regional priorities around inclusive growth, and building on the Charity's work through the introduction of our impact-led five-year strategy, strengthening our position as a recognised centre of excellence in community-led STEM engagement and progressing towards our ambition of national influence. 

We will continue to establish CSC as a leading STEM experience in East Anglia, reaching new audiences and developing high-quality, curiosity-led exhibitions and programmes that translate real-world challenges into 

Page 5 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

**CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

**TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025** 

accessible and engaging ways to explore STEM. We will enhance the visitor journey, ensuring that every interaction is inspiring and supports a lifelong connection with STEM. 

We will further develop our successful multi-partner approach, deepening collaboration with businesses, researchers and industry leaders. Through our Partner, Translate and Engage model, we will continue to deliver hands-on, age-appropriate STEM experiences that are rooted in real-world context, extend into communities facing the greatest barriers, and create meaningful opportunities for young people to engage and participate. 

We will engage strategic leaders and strengthen our role within the sector, contributing to national conversations on STEM engagement and supporting local and regional decision-making on skills, education and community development. This will help shape future talent pipelines and ensure young people can access tangible pathways into STEM careers. 

We will continue to transition towards a secure, diversified and multi-year income model, strengthening our financial resilience and developing our major donor programme. We will broaden our funding base to support the long-term sustainability of the Charity’s work. 

We will further develop our evidence-led approach through our Impact Architecture (Theory of Change), strengthening how we design, deliver and evaluate our programmes. We will continue to work with academic partners, including the University of Cambridge, the University of Bath and Anglia Ruskin University, to deepen our understanding of how young people engage with STEM and how impact can be sustained over time. 

We will continue to invest in our people, strengthening our science communicator model through training, development and clear progression pathways, supporting high-quality delivery and long-term organisational capability. 

## **STRUCTURE, GOVERNANCE AND MANAGEMENT** 

## **Governing document** 

Cambridge Science Centre is a company limited by guarantee and a registered charity governed by its Memorandum and Articles of Association, Charity number 1146349, Company registered number 07962584. 

## **Organisational structure and decision making process** 

The Board of Trustees administers the Charity. The Board meets at least four times per year to review performance and make strategic decisions. Additional meetings of the Board may be called as necessary to manage major activities of the Charity. The Board approves an annual budget and programme of activity for the Charity. Deviations from plan or budget are reviewed at Board of Trustees meetings or more frequently in the case of exceptional circumstance. The Board seeks unanimity in decision making, but resolutions are passed by simple majority if necessary. 

The Chief Executive Officer is appointed by the Trustees to manage the day to day operations of Cambridge Science Centre and has been supported by a management team comprising the Director of Business Development, Director of Programme & Impact, Director of Operations & Engagement, Marketing & Communications Manager, part time Finance Director and HR support. 

The following trustees served during the year: 

Ms H E Fear MBE, Chair Ms A H East Dr L J Spokes Prof J Drori CBE Mr J J P Marsh 

Page 6 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE** 

## **(A Company Limited by Guarantee)** 

## **TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025** 

Ms A J Weatherup Dr J A Mellad (resigned 10th December 2025) Mr B F V Cotta Mr D Cuff Ms S Macmillan 

## **Key management and personnel remuneration** 

The Trustees consider the Board of Trustees and the Chief Executive as comprising the key management personnel of the Charity in charge of directing and controlling the Charity and running and operating the Charity on a day to day basis.  All trustees give their time freely and no trustee remuneration was paid in the period. Details of trustee expenses and related party transactions are disclosed in notes 13 and 29 to the accounts. 

Trustees are required to disclose all relevant interests and register them with the Chief Executive and in accordance with the Trust’s policy withdraw from decisions where a conflict of interest arises. 

The pay of all the Charity’s staff was reviewed in December 2025 by the Remuneration Subcommittee, comprising the Chairman and two other Trustees, and will continue to be reviewed annually and normally increased in accordance with average earnings. The remuneration is benchmarked with charities of a similar size and activity to ensure that the remuneration set is fair and not out of line with that generally paid for similar roles. 

## **Recruitment and appointment of the Trustees** 

As set out in the Articles of Association, the Board of Trustees comprises not fewer than three and not more than twelve persons. All Trustees are appointed for a term of three years and are eligible to be reappointed once to serve a further three year term. In exceptional circumstances, and with the unanimous agreement of the Trustees, a Trustee’s term of office may be extended beyond six years. 

New Trustees are ordinarily selected in a process involving advertising the position publicly and a formal interview.  Candidates are selected based on a number of criteria, including the diversity of the Trustees, as well as a balance of expertise or interests coming from the following communities: commercial sector including public, private and not for profit business; academic and research institutions; science centre and museum industry; school and education for children and young adults; and the arts. No individuals outside of Cambridge Science Centre are responsible for the appointment of Trustees.  In exceptional circumstances the Board can decide to run a different process with a selected individual or individuals, where the expertise required is very focused and niche. This will still include one or more meetings with the Chair and Trustees in advance of a decision to appoint being made. 

## **Induction of Trustees** 

Trustees receive a briefing from the CEO and/or Chair as part of their induction. They are briefed on the objectives of Cambridge Science Centre and how our activities meet those objectives. They are provided with a copy of the Memorandum and Articles of Association, a copy of the most recent Financial Report and copy of the Trustee Policy which they are expected to sign. 

A pack of CSC governance policy documents and minutes from the Board of Trustees’ meetings over the prior six months are available on request. 

A new Trustee is introduced to each member of the Board of Trustees by the Chair at the next Board meeting following their induction. 

Page 7 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **Group structure** 

Cambridge Science Enterprises Limited (Company Number 07584257) is our wholly owned subsidiary, which was set up to manage non charitable trading activities when these become material to the business. The company is currently dormant. 

## **INFORMATION ON FUNDRAISING PRACTICES** 

Cambridge Science Centre is committed to transparency of our operations, including fundraising, and to ensuring that all donations received are used to achieve our STEM engagement objectives. Our means of generating income and our funders do not conflict with our independence as an educational charity and reflect the values of the CSC.  We work to ensure we are fully aware of changes to regulations and to best practice within fundraising, registering with the Fundraising Regulator and the Fundraisers Code of Practice. 

We received no complaints about fundraising activities during 2025. 

## **TRUSTEES' RESPONSIBILITIES STATEMENT** 

The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). 

Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to: 

- select suitable accounting policies and then apply them consistently; 

- observe the methods and principles of the Charities SORP (FRS 102); 

- make judgments and accounting estimates that are reasonable and prudent; 

- state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements; 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business. 

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company's transactions and disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

Approved by order of the members of the board of Trustees and signed on their behalf by: 


**Ms H E Fear MBE Trustee** 

> Date: 06 August 2026 

Page 8 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF  CAMBRIDGE SCIENCE CENTRE** 

## **OPINION** 

We have audited the financial statements of Cambridge Science Centre (the 'charity') for the year ended 31 December 2025 which comprise the Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). 

In our opinion the financial statements: 

- give a true and fair view of the state of the charitable company's affairs as at 31 December 2025 and of its incoming resources and application of resources, including its income and expenditure for the year then ended; 

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and 

- have been prepared in accordance with the requirements of the Companies Act 2006. 

## **BASIS FOR OPINION** 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

## **CONCLUSIONS RELATING TO GOING CONCERN** 

In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. 

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report. 

Page 9 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

**INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF  CAMBRIDGE SCIENCE CENTRE (CONTINUED)** 

## **OTHER INFORMATION** 

The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The Trustees are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. 

We have nothing to report in this regard. 

## **OPINION ON OTHER MATTERS PRESCRIBED BY THE COMPANIES ACT 2006** 

In our opinion, based on the work undertaken in the course of the audit: 

- the information given in the Trustees' Report for the financial year for which the financial statements are prepared is consistent with the financial statements. 

- the Trustees' Report has been prepared in accordance with applicable legal requirements. 

## **MATTERS ON WHICH WE ARE REQUIRED TO REPORT BY EXCEPTION** 

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees' Report. 

We have nothing to report in respect of the following matters in relation to which Companies Act 2006 requires us to report to you if, in our opinion: 

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or 

- the financial statements are not in agreement with the accounting records and returns; or 

- certain disclosures of Trustees' remuneration specified by law are not made; or 

- we have not received all the information and explanations we require for our audit; or 

- the Trustees were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemptions in preparing the Trustees' Report and from the requirement to prepare a Strategic Report. 

## **RESPONSIBILITIES OF TRUSTEES** 

As explained more fully in the Trustees' Responsibilities Statement, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. 

Page 10 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

**INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF  CAMBRIDGE SCIENCE CENTRE (CONTINUED)** 

In preparing the financial statements, the Trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so. 

## **AUDITORS' RESPONSIBILITIES FOR THE AUDIT OF THE FINANCIAL STATEMENTS** 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: 

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows: 

- the engagement partner ensured that the engagement team collectively had the appropriate competence, 

- capabilities and skills to identify or recognise non-compliance with applicable laws and regulations; 

- we identified the laws and regulations applicable to the charitable company through discussions with 

- trustees and other management, and from our commercial knowledge and experience of the charity sector; 

- we focused on specific laws and regulations which we considered may have a direct material effect on the 

- financial statements or the operations of the charitable company, including the Companies Act 2006, Charities Act 2011 and taxation legislation; 

- in addition, we considered provisions of other laws and regulations which do not have a direct effect on the 

- financial statements but compliance with which might be fundamental to the company's ability to operate or to avoid material penalties; 

- we obtained an understanding of the legal and regulatory framework applicable to the Charitable 

- Company and of the Charitable Company’s policies and procedures on compliance with laws and regulations, including documentation of any instances of non-compliance; 

- we made enquiries of management as to where they considered there was susceptibility to fraud, their 

- knowledge of actual, suspected and alleged fraud; 

- we considered the internal controls in place to mitigate risks of fraud and non-compliance with laws and 

- regulations; 

- we obtained an understanding of the entity’s risk assessment process, including the risk of fraud; 

- we assessed the susceptibility of the entity’s financial statements to material misstatement, including how 

- fraud might occur; 

Page 11 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF  CAMBRIDGE SCIENCE CENTRE (CONTINUED)** 

- laws and regulations identified were communicated within the audit team regularly and the team remained 

- alert to instances of non-compliance throughout the audit. 

As a result of the above risk assessment procedures we identified the greatest risk of material misstatement on the financial statements arising from irregularities and fraud to be within the potential for management to override controls together with the risk of fraudulent revenue recognition. We considered the risk of fraudulent revenue recognition to be most prevalent in the cut-off of revenue. In response to these identified risks, we designed procedures which included, but were not limited to: 

- performed analytical procedures to identify any unusual or unexpected relationships; 

- performed audit work over the risk of management override of controls, including testing of journal entries 

- and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business; 

- we evaluated the assumptions and judgements used by management within significant accounting 

- estimates and assessed whether these indicated evidence of management bias; 

- we used Audit Data Analytics to review the client data for unusual trends/anomalies; 

- performed substantive testing for a sample of transactions from client records to supporting 

- documentation and receipts to ensure that all income was appropriately recognised in the correct period and any restrictions appropriately recognised. 

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to: 

- we agreed the financial statement disclosures to underlying supporting documentation; 

- we assessed the extent of compliance with the laws and regulations identified above through making 

- enquiries of management and inspecting legal correspondence; 

- we read the minutes of meetings of those charged with governance; 

- we discussed with management actual and potential litigation and claims; 

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non compliance. Auditing standards also limit the audit procedures required to identify non compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. 

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion. 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' Report. 

Page 12 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF  CAMBRIDGE SCIENCE CENTRE (CONTINUED)** 

## **USE OF OUR REPORT** 

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed. 

**Michael Hewett (Senior Statutory Auditor)** for and on behalf of 

## **PEM Audit Limited** 

Registered auditors Salisbury House Station Road Cambridge CB1 2LA 

Date: 12 August 2026 

Page 13 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2025** 

|**Note**<br>**INCOME FROM:**<br>Grants and donations<br>4<br>Charitable activities<br>5<br>Other trading activities<br>6<br>Investments<br>7<br>**TOTAL INCOME**<br>**EXPENDITURE ON:**<br>Raising funds<br>8<br>Charitable activities<br>9<br>**TOTAL EXPENDITURE**<br>**NET MOVEMENT IN FUNDS**<br>**RECONCILIATION OF FUNDS:**<br>Total funds brought forward<br>Net movement in funds<br>**TOTAL FUNDS CARRIED FORWARD**|**Restricted**<br>**funds**<br>**2025**<br>**£**<br>**448,005**<br>**-**<br>**-**<br>**-**<br>**448,005**<br>**-**<br>**329,894**<br>**329,894**<br>**118,111**<br>**194,286**<br>**118,111**<br>**312,397**|**Unrestricted**<br>**funds**<br>**2025**<br>**£**<br>**724,355**<br>**218,137**<br>**16,722**<br>**2,590**<br>**961,804**<br>**124,279**<br>**762,374**<br>**886,653**<br>**75,151**<br>**161,677**<br>**75,151**<br>**236,828**|**Total**<br>**funds**<br>**2025**<br>**£**<br>**1,172,360**<br>**218,137**<br>**16,722**<br>**2,590**<br>**1,409,809**<br>**124,279**<br>**1,092,268**<br>**1,216,547**<br>**193,262**<br>**355,963**<br>**193,262**<br>**549,225**|As restated<br>Total<br>funds<br>2024<br>£<br>855,134<br>115,528<br>7,356<br>3,556<br>981,574|
|---|---|---|---|---|
|||||99,495<br>817,332<br>916,827|
|||||64,747|
|||||291,216<br>64,747<br>355,963|



The Statement of Financial Activities includes all gains and losses recognised in the year. 

The notes on pages 18 to 40 form part of these financial statements. 

Page 14 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee) REGISTERED NUMBER: 07962584** 

## **BALANCE SHEET AS AT 31 DECEMBER 2025** 

|**Note**<br>**FIXED ASSETS**<br>Intangible assets<br>14<br>Tangible assets<br>15<br>Investments<br>16<br>**CURRENT ASSETS**<br>Stocks<br>17<br>Debtors<br>18<br>Cash at bank and in hand<br>**CURRENT LIABILITIES**<br>Creditors: amounts falling due within one<br>year<br>19<br>**NET CURRENT ASSETS**<br>**TOTAL ASSETS LESS CURRENT**<br>**LIABILITIES**<br>Provisions for liabilities<br>**NET ASSETS**<br>**CHARITY FUNDS**<br>Restricted funds<br>22<br>Unrestricted funds<br>22<br>**TOTAL FUNDS**|**6,299**<br>**86,011**<br>**404,964**<br>**497,274**<br>**(112,139)**|**2025**<br>**£**<br>**19,133**<br>**188,307**<br>**1**<br>**207,441**<br>**385,135**<br>**592,576**<br>**(43,351)**<br>**549,225**<br>**312,397**<br>**236,828**<br>**549,225**|4,140<br>79,523<br>164,766<br>248,429<br>(98,629)|As restated<br>2024<br>£<br>24,733<br>224,780<br>1<br>249,514<br>149,800<br>399,314<br>(43,351)<br>355,963<br>194,286<br>161,677<br>355,963|
|---|---|---|---|---|



The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements. 

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime. 

Page 15 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

# **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee) REGISTERED NUMBER: 07962584** 

# **BALANCE SHEET (CONTINUED) AS AT 31 DECEMBER 2025** 

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by: 


## **Ms H E Fear MBE Trustee** 

Date: 06 August 2026 

The notes on pages 18 to 40 form part of these financial statements. 

Page 16 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE** 

## **(A Company Limited by Guarantee)** 

## **STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2025** 

|**Note**<br>**CASH FLOWS FROM OPERATING ACTIVITIES**<br>Net cash used in operating activities<br>24<br>**CASH FLOWS FROM INVESTING ACTIVITIES**<br>Dividends, interests and rents from investments<br>Purchase of tangible fixed assets<br>**NET CASH USED IN INVESTING ACTIVITIES**<br>**CHANGE IN CASH AND CASH EQUIVALENTS IN THE YEAR**<br>Cash and cash equivalents at the beginning of the year<br>**CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR**<br>25|**2025**<br>**£**<br>**259,171**<br>**2,590**<br>**(21,563)**<br>**(18,973)**<br>**240,198**<br>**164,766**<br>**404,964**|2024<br>£<br>63,589<br>3,556<br>(150,395)<br>**(146,839)**<br>**(83,250)**<br>248,016<br>164,766|
|---|---|---|



The notes on pages 18 to 40 form part of these financial statements 

Page 17 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

**NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **1. GENERAL INFORMATION** 

The Charity is a private company limited by guarantee and incorporated in England. Its registered office, and principal place of business, is Unit 44, Clifton Road, Cambridge, CB1 7ED. 

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied unless otherwise stated. 

The functional and presentational currency of the Charity is GBP. These accounts have been rounded to the nearest pound. 

## **2. ACCOUNTING POLICIES** 

## **2.1 BASIS OF PREPARATION OF FINANCIAL STATEMENTS** 

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. 

Cambridge Science Centre meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy. 

## **2.2 GOING CONCERN** 

At the year end the Charity had net assets of £549,225 including unrestricted funds of £236,828. 

The Board prepares annual budgets and three year plans and these assume the success of various grant applications and Executive Council support. However, if these do not come to fruition, it has made contingency plans to ensure the Charity continues as a going concern. 

During 2025, and since the year end, the Charity has demonstrated its resilience both in terms of delivery against its charitable objectives and maintaining fund raising capabilities. The Development team is constantly monitoring the general funding environment and continues to refine its fundraising efforts accordingly. 

One major donor will continue to provide a guarantee to make up any shortfall if Cambridge Science Centre has to cease its activities and its unrestricted reserves are insufficient to meet all of its liabilities. This guarantee is limited to an aggregate amount of £137,500 (reducing as unrestricted reserves increase) and is enforceable until May 2027. 

The Trustees do not consider there to be any material uncertainties about the Charity’s ability to continue as a going concern for a period of at least 12 months from the date of signing of these accounts. 

Page 18 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **2. ACCOUNTING POLICIES (CONTINUED)** 

## **2.3 FUND ACCOUNTING** 

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes. 

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements. 

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements. 

Investment income, gains and losses are allocated to the appropriate fund. 

## **2.4 INCOME** 

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably. 

Grants are included in the Statement of Financial Activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance Sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued. 

Income from the sale of merchandise is recognised upon delivery to the customer. 

Executive council membership income is recognised immediately upon receipt, reflecting the fact that it is akin to donation income. 

Income from the provision of outreach visits and events is recognised immediately after the visits and events. 

## **2.5 INTEREST RECEIVABLE** 

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited. 

## **2.6 GOVERNMENT GRANTS** 

Government grants relating to tangible fixed assets are treated as deferred income and released to the Statement of Financial Activities upon the completion of the relevant performance-related conditions. Other grants that are not subject to performance-related conditions are credited to the Statement of Financial Activities as the grant proceeds are received. Grants received prior to the revenue recognition criteria being satisfied are recognised as a liability. 

Page 19 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

**CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

**NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **2. ACCOUNTING POLICIES (CONTINUED)** 

## **2.7 EXPENDITURE** 

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. 

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use. 

Support costs are those costs incurred directly in support of expenditure on the objects of the Charity and include central project management costs. 

Governance costs are those incurred in connection with administration of the Charity and compliance with constitutional and statutory requirements. 

All expenditure is accounted for on an accruals basis. All expenses including support costs and governance costs are allocated to applicable expenditure headings. 

All expenditure is inclusive of irrecoverable VAT. 

Expenditure on raising funds includes all expenditure incurred by the Charity to raise funds for its charitable purposes and includes costs of all fundraising activities events and non-charitable trading. 

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs. 

## **2.8 INTANGIBLE ASSETS AND AMORTISATION** 

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. 

Amortisation is provided on intangible assets at rates calculated to write off the cost of each asset on a straight-line basis over its expected useful life. In the prior year amortisation was originally calculated at 25% however on review of the useful life it was deemed that 20% was a more accurate basis and has been used for the current financial year. 

Amortisation is provided on the following basis: 

Website - 20 % Straight line 

Page 20 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE** 

## **(A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **2. ACCOUNTING POLICIES (CONTINUED)** 

## **2.9 TANGIBLE FIXED ASSETS AND DEPRECIATION** 

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost. 

At each reporting date the Charity assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined to be the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount. 

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, using the straight-line method. 

Depreciation is provided on the following basis: 

|Leasehold improvements|-|20% straight line|
|---|---|---|
|Motor vehicles|-|20% straight line|
|Fixtures and fittings|-|25% straight line|
|Exhibit costs|-|20% straight line|



## **2.10 INVESTMENTS** 

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of Financial Activities. 

Investments in subsidiaries are valued at cost less provision for impairment. 

## **2.11 STOCKS** 

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. 

## **2.12 DEBTORS** 

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due. 

## **2.13 CASH AT BANK AND IN HAND** 

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account. 

Page 21 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

**NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **2. ACCOUNTING POLICIES (CONTINUED)** 

## **2.14 LIABILITIES** 

Liabilities and provisions are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. 

Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide. 

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost. 

## **2.15 FINANCIAL INSTRUMENTS** 

The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method. 

## **2.16 OPERATING LEASES** 

Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight-line basis over the lease term. 

## **2.17 PENSIONS** 

The Charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charity to the fund in respect of the year. 

Page 22 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **3. CRITICAL ACCOUNTING ESTIMATES AND AREAS OF JUDGEMENT** 

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. 

Critical accounting estimates and assumptions: 

The Charity makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below. 

Critical areas of judgement: 

## **Dilapidations provision** 

The Charity leases property at Unit 44, Clifton Road, Cambridge. At the end of the lease in 2028 (2026 if the break clause is invoked), the Charity will be required to carry out remedial work. As disclosed in note 20, the cost is expected to be £43,351. This estimate is subject to many estimates and assumptions, including the discount rates and future inflation. 

## **4. INCOME FROM GRANTS AND DONATIONS** 

|Donations and grants<br>Executive Council Membership<br>TOTAL 2024 AS RESTATED|**Restricted**<br>**funds**<br>**2025**<br>**As restated**<br>**Unrestricted**<br>**funds**<br>**2025**<br>**£**<br>**£**<br>448,005<br>570,215<br>-<br>154,140<br>448,005<br>724,355<br>514,760<br>340,374|**Total**<br>**funds**<br>**2025**<br>**£**<br>**1,018,220**<br>**154,140**<br>**1,172,360**<br>855,134|As restated<br>Total<br>funds<br>2024<br>£<br>679,273<br>175,861<br>855,134|
|---|---|---|---|
|||||



## **5. INCOME FROM CHARITABLE ACTIVITIES** 

|**Unrestricted**<br>**funds**<br>**2025**<br>**£**<br>Admissions and outreach<br>218,137<br>TOTAL 2024<br>115,528|**Total**<br>**funds**<br>**2025**<br>**£**<br>**218,137**<br>115,528|Total<br>funds<br>2024<br>£<br>115,528|
|---|---|---|
||||



Page 23 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **6. INCOME FROM OTHER TRADING ACTIVITIES** 

**Income from non charitable trading activities** 

|**Unrestricted**<br>**funds**<br>**2025**<br>**£**<br>Retail sales<br>16,722<br>TOTAL 2024<br>7,356<br>**INVESTMENT INCOME**<br>**Unrestricted**<br>**funds**<br>**2025**<br>**£**<br>Bank interest<br>2,590<br>TOTAL 2024<br>3,556|**Total**<br>**funds**<br>**2025**<br>**£**<br>**16,722**<br>7,356<br>**Total**<br>**funds**<br>**2025**<br>**£**<br>**2,590**<br>3,556|Total<br>funds<br>2024<br>£<br>7,356|
|---|---|---|
|||Total<br>funds<br>2024<br>£<br>3,556|
||||



## **7. INVESTMENT INCOME** 

Page 24 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **8. EXPENDITURE ON RAISING FUNDS** 

|**Unrestricted**<br>**funds**<br>**2025**<br>**£**<br>Events, exhibits and advertising<br>7,016<br>Training<br>-<br>Premises rent<br>3,079<br>Office expenses<br>199<br>Professional and consultancy<br>11,900<br>Staff costs<br>101,880<br>Depreciation<br>205<br>124,279<br>TOTAL 2024<br>99,495|**Total**<br>**funds**<br>**2025**<br>**£**<br>**7,016**<br>**-**<br>**3,079**<br>**199**<br>**11,900**<br>**101,880**<br>**205**<br>**124,279**<br>99,495|Total<br>funds<br>2024<br>£<br>6,141<br>39<br>-<br>-<br>-<br>93,315<br>-<br>99,495|
|---|---|---|
||||



Page 25 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **9. ANALYSIS OF EXPENDITURE ON CHARITABLE ACTIVITIES** 

## **Summary by fund type** 

|**Restricted**<br>**funds**<br>**2025**<br>**Unrestricted**<br>**funds**<br>**2025**<br>**£**<br>**£**<br>Events and Outreach<br>329,894<br>762,374<br>TOTAL 2024<br>529,456<br>287,876<br>**10.**<br>**ANALYSIS OF EXPENDITURE BY ACTIVITIES**|**Total**<br>**2025**<br>**£**<br>**1,092,268**<br>817,332|Total<br>2024<br>£<br>817,332|
|---|---|---|
||||



|Events and Outreach<br>TOTAL 2024<br>**ANALYSIS OF DIRECT COSTS**<br>Staff costs<br>Depreciation<br>Events, exhibits and advertising<br>TOTAL 2024|**Activities**<br>**undertaken**<br>**directly**<br>**2025**<br>**£**<br>504,614<br>325,202|**Support**<br>**costs**<br>**2025**<br>**£**<br>587,654<br>492,130<br>**Events and**<br>**Outreach**<br>**2025**<br>**£**<br>278,183<br>44,996<br>181,435<br>504,614<br>325,202|**Total**<br>**funds**<br>**2025**<br>**£**<br>**1,092,268**<br>817,332<br>**Total**<br>**funds**<br>**2025**<br>**£**<br>**278,183**<br>**44,996**<br>**181,435**<br>**504,614**<br>325,202|Total<br>funds<br>2024<br>£<br>817,332|
|---|---|---|---|---|
|||||Total<br>funds<br>2024<br>£<br>223,783<br>29,986<br>71,433<br>325,202|
||||||



Page 26 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **10. ANALYSIS OF EXPENDITURE BY ACTIVITIES (CONTINUED)** 

## **ANALYSIS OF SUPPORT COSTS** 

|**Events and**<br>**Outreach**<br>**2025**<br>**£**<br>Staff costs<br>315,696<br>Depreciation<br>18,435<br>Rent<br>132,923<br>Membership fees<br>2,919<br>Rates and utilities<br>2,504<br>Office equipment<br>4,966<br>Phone and internet<br>13,622<br>Other premises costs<br>23,459<br>Legal and professional fees<br>52,692<br>Storage<br>150<br>Governance costs<br>20,288<br>587,654<br>TOTAL 2024<br>492,130<br>**11.**<br>**AUDITORS'/INDEPENDENT EXAMINER'S REMUNERATION**<br>Fees payable to the Charity's auditor (2024: independent examiner) for the<br>audit (2024: independent examination) of the Charity's annual accounts<br>Fees payable to the Charity's auditor (2024: independent examiner) in<br>respect of:<br>Preparation of the annual accounts|**Total**<br>**funds**<br>**2025**<br>**£**<br>**315,696**<br>**18,435**<br>**132,923**<br>**2,919**<br>**2,504**<br>**4,966**<br>**13,622**<br>**23,459**<br>**52,692**<br>**150**<br>**20,288**<br>**587,654**<br>492,130<br>**2025**<br>**£**<br>**12,500**<br>**2,500**|Total<br>funds<br>2024<br>£<br>211,090<br>12,775<br>131,378<br>27,228<br>1,124<br>8,698<br>7,743<br>19,313<br>51,045<br>2,829<br>18,907<br>492,130|
|---|---|---|
|||2024<br>£<br>1,500<br>3,000|



Page 27 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE** 

## **(A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **12. STAFF COSTS** 

|Wages and salaries<br>Social security costs<br>Contribution to defined contribution pension schemes|**2025**<br>**£**<br>**609,187**<br>**71,470**<br>**15,102**<br>**695,759**|2024<br>£<br>477,548<br>37,949<br>12,691|
|---|---|---|
|||528,188|



During the year, the Charity made payments to two staff totalling £27,040 in connection with staff restructuring. These included statutory and contractual entitlements (such as redundancy, notice pay and accrued leave), along with ex-gratia compensation payments of £9,000 made to two employees. All amounts were approved in line with internal governance procedures and employment law. 

The average number of persons employed by the Charity during the year was as follows: 

|Delivery<br>Business Development<br>Central<br>Exhibitions|**2025**<br>**No.**<br>**17**<br>**1**<br>**3**<br>**1**<br>**22**|2024<br>No.<br>10<br>2<br>2<br>1|
|---|---|---|
|||15|



The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was: 

|||**2025**|2024|
|---|---|---|---|
|||**No.**|No.|
|In the band £60,001|- £70,000|**-**|1|
|In the band £70,001|- £80,000|**-**|1|
|In the band £90,001|- £100,000|**1**|-|



During the year, the key management personnel of the Charity comprised the Trustees and the Chief Executive Officer. The total employee benefits of the key management personnel of the Charity including employer's national insurance and pension contributions were £114,264 (2024 - £100,452). 

## **13. TRUSTEES' REMUNERATION AND EXPENSES** 

During the year, no Trustees received any remuneration or other benefits (2024 - £NIL). 

Page 28 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **13. TRUSTEES' REMUNERATION AND EXPENSES (CONTINUED)** 

During the year ended 31 December 2025, expenses totalling £139 were reimbursed or paid directly to 2 Trustees (2024 - £13 paid to 1 Trustee). The reimbursement covered Companies House filing fees, travel and subsistence. 

## **14. INTANGIBLE ASSETS** 

|**COST**<br>At 1 January 2025<br>At 31 December 2025<br>**AMORTISATION**<br>At 1 January 2025<br>Charge for the year<br>At 31 December 2025<br>**NET BOOK VALUE**<br>At 31 December 2025<br>At 31 December 2024|**Website**<br>**£**<br>**28,000**|
|---|---|
||**28,000**|
||**3,267**<br>**5,600**|
||**8,867**|
|||
||**19,133**|
||24,733|



Page 29 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **15. TANGIBLE FIXED ASSETS** 

|**Leasehold**<br>**improvements**<br>**£**<br>**COST**<br>At 1 January 2025<br>**135,798**<br>Additions<br>**1,452**<br>At 31 December 2025<br>**137,250**<br>**DEPRECIATION**<br>At 1 January 2025<br>**122,331**<br>Charge for the year<br>**4,100**<br>At 31 December 2025<br>**126,431**<br>**NET BOOK VALUE**<br>At 31 December 2025<br>**10,819**<br>At 31 December 2024<br>13,467<br>**16.**<br>**FIXED ASSET INVESTMENTS**|**Motor**<br>**vehicles**<br>**£**<br>**27,719**<br>**-**<br>**27,719**<br>**8,316**<br>**5,544**<br>**13,860**<br>**13,859**<br>19,403|**Fixtures,**<br>**fittings and**<br>**equipment**<br>**£**<br>**65,469**<br>**9,257**<br>**74,726**<br>**48,104**<br>**7,888**<br>**55,992**<br>**18,734**<br>17,365|**Exhibit**<br>**costs**<br>**£**<br>**407,852**<br>**10,854**<br>**418,706**<br>**233,307**<br>**40,504**<br>**273,811**<br>**144,895**<br>174,545|**Total**<br>**£**<br>**636,838**<br>**21,563**<br>**658,401**|
|---|---|---|---|---|
|||||**412,058**<br>**58,036**<br>**470,094**|
|||||**188,307**|
|||||224,780|
||||||



|**COST**<br>At 1 January 2025<br>AT 31 DECEMBER 2025|**Investments**<br>**in**<br>**subsidiary**<br>**companies**<br>**£**<br>**1**|
|---|---|
||**1**|



Page 30 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **16. FIXED ASSET INVESTMENTS (CONTINUED)** 

## **PRINCIPAL SUBSIDIARIES** 

The following was a subsidiary undertaking of the Charity: 

**Name Company Registered office or principal Principal activity number place of business** Cambridge Science Enterprises 07584257 Unit 44, Clifton Road, Cambridge, Dormant Limited (dormant) CB1 7ED 

**Class of Holding shares** Ordinary 100% 

The financial results of the subsidiary for the year were: 

||**Name**||**Net**|
|---|---|---|---|
||||**liabilities**|
||||**£**|
||Cambridge Science Enterprises Limited (dormant)||**132**|
|**17.**|**STOCKS**|||
|||**2025**|2024|
|||**£**|£|
||Shop merchandise|**6,299**|4,140|



Page 31 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE** 

## **(A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **18. DEBTORS** 

|**DUE AFTER MORE THAN ONE YEAR**<br>Other debtors<br>**DUE WITHIN ONE YEAR**<br>Trade debtors<br>Amounts owed by group undertakings<br>Other debtors<br>Prepayments|**2025**<br>**£**<br>**22,781**<br>**17,200**<br>**159**<br>**2,954**<br>**42,917**<br>**86,011**|2024<br>£<br>22,781<br>9,860<br>159<br>797<br>45,926|
|---|---|---|
|||79,523|



## **19. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR** 

|Trade creditors<br>Other taxation and social security<br>Other creditors<br>Accruals and deferred income<br>Deferred income at 1 January 2025<br>Resources deferred during the year<br>Amounts released from previous periods|**2025**<br>**£**<br>**28,742**<br>**29,110**<br>**574**<br>**53,713**<br>**112,139**<br>**2025**<br>**£**<br>**13,299**<br>**13,379**<br>**(13,299)**<br>**13,379**|As restated<br>2024<br>£<br>24,998<br>13,009<br>3,358<br>57,264|
|---|---|---|
|||98,629|
|||As restated<br>2024<br>£<br>71,785<br>13,299<br>(71,785)|
|||13,299|



Deferred income relates to outreach school visits, birthday parties and corporate sponsorship paid in advance. 

Page 32 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **20. PROVISIONS** 

|||||**Dilapidations**|
|---|---|---|---|---|
|||||**£**|
|At|1|January|2025|**43,351**|



The Charity has the obligation to make good dilapidations or other damage which occurs to the property during the course of the lease. The obligation is expected to be settled at the end of the lease on Unit 44 in 2028. 

## **21. PRIOR YEAR ADJUSTMENTS** 

In the prior year, executive council membership income received during the year was deferred and spread over a period of 12 months. This income is non-refundable and the substance of the subscriptions received are in the nature of a gift. Accordingly, these membership fees should have been recognised on the same basis as a donation and recognised in the Statement of Financial Activities immediately upon receipt. The prior-year comparatives have therefore been restated to correct this error, affecting the following line items: 

- Executive Council Membership income disclosed in income from grants and donations in note 4 and in the Statement of Financial Activities has increased by £10,834, resulting in a corresponding increase in the net movement in funds. 

- Accruals and deferred income reported in note 19 has decreased by £34,167, reducing creditors amounts falling due within one year on the Balance Sheet by the same amount. 

- Opening and closing general unrestricted funds reported in note 22, the Balance Sheet and the Statement of Financial Activities have increased by £23,333 and £34,167, respectively. 

Page 33 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **22. STATEMENT OF FUNDS STATEMENT OF FUNDS - CURRENT YEAR** 

|**UNRESTRICTED FUNDS**<br>General<br>Capital fund<br>**RESTRICTED FUNDS**<br>BGO Newton<br>Brockton Everlast Inc. Limited<br>Centre for Landscape<br>Regeneration<br>Debbie Allen<br>Edina Trust<br>Johnson Matthey<br>LifeArc<br>Roche<br>Other restricted funds<br>Building a Better Future<br>**TOTAL OF FUNDS**|**As restated**<br>**Balance at 1**<br>**January**<br>**2025**<br>**£**<br>**(87,836)**<br>**249,513**<br>**161,677**<br>**10,833**<br>**15,660**<br>**5,000**<br>**81,000**<br>**6,900**<br>**-**<br>**21,218**<br>**30,000**<br>**23,675**<br>**-**<br>**194,286**<br>**355,963**|**Income**<br>**£**<br>**961,804**<br>**-**<br>**961,804**<br>**-**<br>**20,000**<br>**-**<br>**80,000**<br>**-**<br>**4,000**<br>**50,000**<br>**-**<br>**243,005**<br>**51,000**<br>**448,005**<br>**1,409,809**|**Expenditure**<br>**£**<br>**(886,653)**<br>**-**<br>**(886,653)**<br>**(10,833)**<br>**(15,313)**<br>**(5,000)**<br>**(62,000)**<br>**(6,900)**<br>**(4,000)**<br>**(51,218)**<br>**(30,000)**<br>**(144,630)**<br>**-**<br>**(329,894)**<br>**(1,216,547)**|**Transfers**<br>**in/out**<br>**£**<br>**42,073**<br>**(42,073)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Balance at**<br>**31**<br>**December**<br>**2025**<br>**£**<br>**29,388**<br>**207,440**<br>**236,828**|
|---|---|---|---|---|---|
||||||**-**<br>**20,347**<br>**-**<br>**99,000**<br>**-**<br>**-**<br>**20,000**<br>**-**<br>**122,050**<br>**51,000**<br>**312,397**|
||||||**549,225**|



Page 34 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **22. STATEMENT OF FUNDS (CONTINUED)** 

## **STATEMENT OF FUNDS - PRIOR YEAR** 

|**UNRESTRICTED FUNDS**<br>General<br>Capital fund<br>**RESTRICTED FUNDS**<br>Association of Science and<br>Discovery Centres (ASDC)<br>BGO Newton<br>Brockton Everlast Inc. Limited<br>CAA - Reach for the Sky<br>Cambridgeshire and<br>Peterborough Combined<br>Authority<br>Cambridgeshire Community<br>Foundation<br>Centre for Landscape<br>Regeneration<br>Debbie Allen<br>Edina Trust<br>Illumina<br>Johnson Matthey<br>LifeArc<br>Roche<br>Other restricted funds<br>**TOTAL OF FUNDS**|As restated<br>Balance at<br>1 January<br>2024<br>£<br>(57,342)<br>139,576<br>82,234<br>-<br>-<br>-<br>-<br>99,736<br>-<br>-<br>-<br>-<br>-<br>10,960<br>90,786<br>-<br>7,500<br>208,982<br>291,216|As restated<br>Income<br>£<br>466,814<br>-<br>466,814<br>13,500<br>32,500<br>20,000<br>70,000<br>-<br>11,120<br>26,500<br>81,000<br>11,900<br>82,160<br>10,000<br>50,000<br>60,000<br>46,080<br>514,760<br>981,574|Expenditure<br>£<br>(387,371)<br>-<br>(387,371)<br>(13,500)<br>(21,667)<br>(4,340)<br>(70,000)<br>(99,736)<br>(11,120)<br>(21,500)<br>-<br>(5,000)<br>(82,160)<br>(20,960)<br>(119,568)<br>(30,000)<br>(29,905)<br>(529,456)<br>(916,827)|Transfers<br>in/out<br>£<br>(109,937)<br>109,937<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-|As restated<br>Balance at<br>31<br>December<br>2024<br>£<br>(87,836)<br>249,513<br>161,677<br>-<br>10,833<br>15,660<br>-<br>-<br>-<br>5,000<br>81,000<br>6,900<br>-<br>-<br>21,218<br>30,000<br>23,675<br>194,286<br>355,963|
|---|---|---|---|---|---|



Page 35 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

# **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **22. STATEMENT OF FUNDS (CONTINUED)** 

CPCA – Market Towns Programme (Phase 2) – Supporting Social Enterprise in towns and villages within Fenland. Delivery of an educational STEM programme via pop ups in local buildings to raise awareness and aspirations for related study and careers. 

LifeArc – Supporting the development of the new Cambridge Science Centre (Explore Zone) and to encourage greater participation in science from underrepresented cohorts by supporting STEM outreach to the secondary school age group in underserved areas. 

Roche – Development and national rollout of a drug discovery-themed STEM Challenge Day, delivered as part of a nationwide STEM outreach programme reaching a minimum of 50 schools. 

Illumina – Funding to support STEM engagement and genomic literacy through the development of a new public-facing Genome Explorers science show, the creation and distribution of DNA-themed educational activities for schools, and attendance at Illumina events to strengthen engagement with schools, communities and wider stakeholders. 

BGO Newton – To engage children and young people in Cherry Hinton and East Cambridge with the Project Newton development, creating meaningful connections between local communities and future opportunities in science, technology and innovation. The project aimed to raise aspirations, inspire interest in STEM, and support young people to explore potential pathways into further education, training and employment. 

Centre for Landscape Regeneration – A collaborative project to develop a modular workshop for upper Key Stage 2 and lower Key Stage 3 pupils, as well as community groups. The workshop will explore the changing nature of the Fenland landscape, alongside training for Science Communicators to support engagement with underserved communities. 

Dr Debbie Allen (Andiamo Foundation) – Funding to support the development and delivery of STEM workshops, exhibits and educational resources, including content for early years audiences. The funding also enabled CSC to expand its community-focused work, developing and delivering programmes in communities across Cambridgeshire, including but not limited to, King's Hedges, Abbey, Arbury and Chesterton. 

Brockton Everlast Limited – Funding for two weekend Science Communicators to support increased visitor activity, alongside a collaborative project to deliver and evaluate pilot activities focused on the built environment. The pilot explored areas of shared interest across different participant groups, with the findings informing the development of future programme content. 

Edina Trust – Funding of transport costs (coach hire) & schools workshops for local primary schools. Schools will receive a transport subsidy and curriculum linked workshops – with a focus on underserved communities. 

East Coast Skills – To support the delivery of activity days in schools across Lincolnshire, within the funder's designated geographic area of focus. 

The Hodge Foundation – Funding to advance science learning and raise aspirations in the Fenlands through the delivery of programmes and activities at the Wisbech Centre. 

The Swire Charitable Trust – Funding to advance science learning and raise aspirations in the Fenlands through the delivery of programmes and activities at the Wisbech Centre. 

Page 36 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

Building a Better Future – Funding to support the development and delivery of Building a Better Future, CSC's new programme exploring the built environment and helping children and young people understand how places are designed, developed and shaped. 

ASDC – Delivery of Explore Your Universe: Valuing Inclusion – A grant to support the delivery and cocreation of this programme, alongside funding for the delivery and evaluation of a programme designed to engage, inspire and involve school-aged children, their families and their teachers in understanding the UK's role in space and the contribution that space can make to the future sustainability of Planet Earth. 

CAA Reach for the Sky Challenge Fund – Delivery of outreach activities designed to improve inclusion, diversity and awareness of career opportunities within the aviation sector, inspiring the next generation of aviation professionals and encouraging under-represented groups to consider careers in aviation. 

Cambridgeshire Community Foundation – To contribute towards the delivery of pop-up science centres across the Fenlands, including funding for school transport to remove barriers to participation and enable greater access to STEM learning opportunities. 

Johnson Matthey – Funding for a Lab station equipped with laboratory tools and materials, enabling visitors to conduct biology-related experiments, alongside the development of a dedicated activity explaining what catalysts are and how they are used in the real world. 

## **23. ANALYSIS OF NET ASSETS BETWEEN FUNDS** 

## **ANALYSIS OF NET ASSETS BETWEEN FUNDS - CURRENT YEAR** 

|Tangible fixed assets<br>Intangible fixed assets<br>Fixed asset investments<br>Debtors due after more than one year<br>Current assets<br>Creditors due within one year<br>Provisions for liabilities and charges<br>**TOTAL**|**Restricted**<br>**funds**<br>**2025**<br>**Unrestricted**<br>**funds**<br>**2025**<br>**£**<br>**£**<br>-<br>188,307<br>-<br>19,133<br>-<br>1<br>-<br>22,781<br>312,397<br>162,096<br>-<br>(112,139)<br>-<br>(43,351)<br>312,397<br>236,828|**Total**<br>**funds**<br>**2025**<br>**£**<br>**188,307**<br>**19,133**<br>**1**<br>**22,781**<br>**474,493**<br>**(112,139)**<br>**(43,351)**<br>**549,225**|
|---|---|---|



Page 37 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **23. ANALYSIS OF NET ASSETS BETWEEN FUNDS (CONTINUED)** 

## **ANALYSIS OF NET ASSETS BETWEEN FUNDS - PRIOR YEAR** 

|Restricted<br>funds<br>2024<br>£<br>Tangible fixed assets<br>-<br>Intangible fixed assets<br>-<br>Fixed asset investments<br>-<br>Debtors due after more than one year<br>-<br>Current assets<br>194,286<br>Creditors due within one year<br>-<br>Provisions for liabilities and charges<br>-<br>**TOTAL**<br>194,286<br>**24.**<br>**RECONCILIATION OF NET MOVEMENT IN FUNDS TO NET CASH FLOW**<br>**ACTIVITIES**<br>Net income/(expenditure) for the year (as per Statement of Financial<br>Activities)<br>**ADJUSTMENTS FOR:**<br>Depreciation charges<br>Dividends, interests and rents from investments<br>Increase in stocks<br>Increase in debtors<br>Increase/(decrease) in creditors<br>**NET CASH PROVIDED BY OPERATING ACTIVITIES**|As restated<br>Unrestricted<br>funds<br>2024<br>As restated<br>Total funds<br>2024<br>£<br>£<br>224,780<br>224,780<br>24,733<br>24,733<br>1<br>1<br>22,781<br>22,781<br>31,362<br>225,648<br>(98,629)<br>(98,629)<br>(43,351)<br>(43,351)<br>161,677<br>355,963<br>**FROM OPERATING**<br>As restated<br>**2025**<br>2024<br>**£**<br>£<br>**193,262**<br>64,747<br>**63,636**<br>40,458<br>**(2,590)**<br>(3,556)<br>**(2,159)**<br>(3,702)<br>**(6,488)**<br>(945)<br>**13,510**<br>(33,413)<br>**259,171**<br>63,589|
|---|---|



Page 38 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **25. ANALYSIS OF CASH AND CASH EQUIVALENTS** 

||**2025**|2024|
|---|---|---|
||**£**|£|
|Cash in hand|**404,964**|164,766|



## **26. ANALYSIS OF CHANGES IN NET DEBT** 

|Cash at bank and in hand|**At 1**<br>**January**<br>**2025**<br>**£**<br>**164,766**<br>**164,766**|**Cash flows**<br>**£**<br>**240,198**<br>**240,198**|**At 31**<br>**December**<br>**2025**<br>**£**<br>**404,964**<br>**404,964**|
|---|---|---|---|



## **27. PENSION COMMITMENTS** 

The Charity operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Charity in an independently administered fund. The pension cost charge represents contributions payable by the Charity to the fund and amounted to £15,102 (2024: £12,691). Contributions totalling £610 were prepaid to the scheme (2024: £2,973 outstanding contributions due to the scheme) at the balance sheet date and are included in debtors (2024: creditors). 

Page 39 



Docusign Envelope ID: CFEAF01C-2DEE-8980-82C6-D62400A07152 

## **CAMBRIDGE SCIENCE CENTRE (A Company Limited by Guarantee)** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **28. OPERATING LEASE COMMITMENTS** 

At 31 December 2025 the Charity had commitments to make future minimum lease payments under noncancellable operating leases as follows: 

|**Premises**<br>Not later than 1 year<br>Later than 1 year and not later than 5 years|**2025**<br>**£**<br>**37,252**<br>**-**<br>**37,252**|2024<br>£<br>63,142<br>38,517|
|---|---|---|
|||101,659|



The following lease payments have been recognised as an expense in the Statement of Financial Activities: 

||**2025**|2024|
|---|---|---|
||**£**|£|
|Operating lease rentals|**138,506**|132,502|



## **29. RELATED PARTY TRANSACTIONS** 

At 31 December 2025, the company held 1 ordinary share of £1 each in the wholly owned subsidiary, Cambridge Science Enterprises Limited, which is registered in the United Kingdom. The Company ceased trading on 31 March 2015 and has remained dormant since that date. At 31 December 2025, the subsidiary owed £159 to the Charity (2024: £159). 

During the year, donations totalling £12,047 were received from two trustees. In addition, a £200,000 donation was received from Relithan Charitable Trust, of which A East is a director. 

During the prior year, donations totalling £16,000 were received from two trusts associated with two trustees (A East and D Cleevely). In addition, the deferred £20,000 donation received from the trust associated with D Cleevely was recognised as income in the Statement of Financial Activities. Donations totalling £12,500 were received from one trustee. 

Page 40 

